Shopping Cart
- Remove All
- Your shopping cart is currently empty
Neuromedin U-25 human, the active form of neuromedin U in humans, inhibits glucose-stimulated insulin secretion, leading to early-onset obesity, and serves as a vasoconstrictor in human vascular beds [1][2].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | Neuromedin U-25 human, the active form of neuromedin U in humans, inhibits glucose-stimulated insulin secretion, leading to early-onset obesity, and serves as a vasoconstrictor in human vascular beds [1][2]. |
In vitro | Neuromedin U-25 human (4 pM-2 nM) binds to receptors in the human left ventricle and coronary artery, with K D values of 0.26 and 0.11 nM, respectively [1]. Additionally, Neuromedin U-25 human (0.1 nM-0.1 μM) induces endothelium-independent contraction in coronary, mammary, and saphenous vessels, with contraction potencies (pD 2) of 8.6, 8.0, and 8.2, respectively [1]. |
Molecular Weight | 3080.37 |
Formula | C141H203N41O38 |
Cas No. | 312306-89-1 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.